Landmark Financial Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$312K Hold
1,152
0.11% 73
2023
Q3
$283K Hold
1,152
0.12% 73
2023
Q2
$350K Hold
1,152
0.14% 67
2023
Q1
$304K Hold
1,152
0.13% 71
2022
Q4
$276K Hold
1,152
0.13% 73
2022
Q3
$212K Buy
+1,152
New +$229K 0.11% 77
2022
Q2
Sell
-1,452
Closed -$306K 82
2022
Q1
$306K Buy
1,452
+45
+3% +$11.3K 0.15% 69
2021
Q4
$361K Buy
+1,407
New +$344K 0.16% 64
2021
Q3
Sell
-1,037
Closed -$214K 71
2021
Q2
$214K Buy
+1,037
New +$211K 0.1% 72
2020
Q2
Sell
-2,300
Closed -$259K 62
2020
Q1
$259K Buy
+2,300
New +$298K 0.18% 55

Other funds holding HCA

Landmark Financial Advisors's HCA Position: Q4 2023 in Review

Landmark Financial Advisors held its HCA Healthcare (HCA) position steady in Q4 2023 at 1,152 shares worth $312K. The position accounts for 0.11% of the portfolio, ranked #73.

Landmark Financial Advisors first reported a position in HCA in Q1 2020 and has held it in 10 quarters since. The position peaked at $361K in Q4 2021. 1,057 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Landmark Financial Advisors held 1,152 shares of HCA Healthcare worth $312K as of Q4 2023.
  • Landmark Financial Advisors left its HCA Healthcare share count unchanged in Q4 2023.
  • HCA Healthcare made up 0.11% of Landmark Financial Advisors's portfolio in Q4 2023, its #73 holding.
  • Landmark Financial Advisors first reported a position in HCA Healthcare in Q1 2020 and has held it in 10 quarters since.
  • Landmark Financial Advisors's HCA Healthcare position peaked at $361K in Q4 2021.
  • 1,057 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Landmark Financial Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.